The Direct Index
Report · scanned 2026-11-13

What an AI agent reads on BioOra Health & Technology Centre

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from bioora.com, taken from the copy the scanner kept.

3,563

characters of text without JavaScript

LocalBusiness

structured data for the business

0

of 3 AI crawlers turned away at the edge

Text

The words an agent gets

Title: BioOra - Automating CAR T-Cell Manufacture · language en-NZ. First 1,800 of 3,563 characters:

BioOra - Automating CAR T-Cell Manufacture 0 Skip to Content Home Our stories Join us Get in touch Open Menu Close Menu Home Our stories Join us Get in touch Open Menu Close Menu Home Our stories Join us Get in touch Advanced cell therapy, delivered closer to homeBioOra develops and manufactures next-generation CAR-T therapies from New Zealand. Improving access, reducing delays, and enabling safe, more scalable delivery of treatments. Contact Us EARLY CLINICAL OBSERVATIONSfrom BioOra’s lead programmeEncouraging complete response rates and favourable safety profile in participants treated in the Phase 1 clinical trial.Read the clinical data.Results are preliminary and subject to change as trials progress.This therapy is not yet approved. Why access to CAR-T therapy matters Limited access today Advanced cell therapies are still difficult to access outside major global centres, with cost, capacity, and location creating barriers for many patients. Time matters For eligible patients, delays in treatment can significantly impact outcomes, while complex delivery pathways can further limit access. Closer delivery changes this Delivering CAR-T therapies locally improves access, shortens timelines, and supports more efficient, scalable delivery of treatment. DESIGNED FOR BETTER OUTCOMESAdvancing CAR-T therapies with a focus on patientsBioOra’s approach prioritises what matters most:Improved tolerabilityDesigned to reduce severe side effects associated with traditional CAR-T therapiesFaster access to treatmentLocal delivery reduces delays between diagnosis and therapyConsistent, scalable deliveryEnabling broader access through a more efficient and scalable model of treatment deliveryAutomated, scalable manufacturingUsing the Cocoon® platform to enable consistent production and sc
Facts

What it can say about the business

A business type in JSON-LDLocalBusiness
NameBioOra
Telephoneno
Addressyes
Opening hoursyes
Menu or price listnothing
Cuisine in structured datano
JSON-LD blocks3 (LocalBusiness, Organization, WebSite)
Actions

The links it would act on

No booking or ordering link found. An agent has nothing to act on.

Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.